Bozko M - Search Results

1

Cholangiocarcinoma Therapeutics: An Update.

Nguyen MLT, Toan NL, Bozko M, Bui KC, Bozko P. Nguyen MLT, et al. Among authors: bozko m. Curr Cancer Drug Targets. 2021;21(6):457-475. doi: 10.2174/1568009621666210204152028. Curr Cancer Drug Targets. 2021. PMID: 33563168 Review.

2

Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?

Podhorecka M, Macheta A, Bozko M, Bozko A, Malek NP, Bozko P. Podhorecka M, et al. Among authors: bozko m. Curr Cancer Drug Targets. 2016;16(8):652-658. doi: 10.2174/1568009616666160427103930. Curr Cancer Drug Targets. 2016. PMID: 27117115 Review.

3

Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy.

Bozko M, Bozko A, Scholta T, Malek NP, Bozko P. Bozko M, et al. Curr Med Chem. 2017;24(15):1487. doi: 10.2174/092986732415170630115722. Curr Med Chem. 2017. PMID: 28728539

4

Cell-to-Cell Transmission of the Unfolded Protein Response - Is it a Real Phenomenon?

Bozko M, Bozko P. Bozko M, et al. Curr Med Chem. 2021;28(22):4586-4587. doi: 10.2174/0929867327999201105163402. Curr Med Chem. 2021. PMID: 33153417

5

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.

Klein SM, Bozko M, Toennießen A, Malek NP, Bozko P. Klein SM, et al. Among authors: bozko m. Curr Med Chem. 2022;29(24):4293-4300. doi: 10.2174/0929867329666220112141211. Curr Med Chem. 2022. PMID: 35023452

6

Editorial (Thematic Issue: Pathogenetic Mechanisms of CLL - A Target in Therapy).

Bozko M, Podhorecka M, Macheta A, Bozko A, Malek NP, Bozko P. Bozko M, et al. Curr Cancer Drug Targets. 2016;16(8):651. doi: 10.2174/156800961608160902101746. Curr Cancer Drug Targets. 2016. PMID: 27758697 No abstract available.

7

Dysregulation of Carnosine Metabolism in Progression of Diseases.

Bozko M, Drozak J, Malek NP, Bozko P. Bozko M, et al. Curr Med Chem. 2020;27(11):1713. doi: 10.2174/092986732711200423112140. Curr Med Chem. 2020. PMID: 32340600 No abstract available.

8

Editorial: Gut microbiota and gastrointestinal diseases: to treat or not to treat.

Bien J, Bozko M, Malek NP, Bozko P. Bien J, et al. Among authors: bozko m. Curr Pharm Des. 2014;20(28):4533-4. Curr Pharm Des. 2014. PMID: 24998646 No abstract available.

9

Editorial: Helicobacter pylori eradication therapy: advantages and disadvantages.

Bien J, Bozko M, Malek NP, Bozko P. Bien J, et al. Among authors: bozko p, bozko m. Curr Pharm Des. 2014;20(28):4487-8. doi: 10.2174/138161282028140704103024. Curr Pharm Des. 2014. PMID: 24998645 No abstract available.

10

Editorial: Gut Microbiota and Gastrointestinal Diseases: to Treat or Not To Treat.

Bien J, Bozko M, P Malek N, Bozko P. Bien J, et al. Among authors: bozko p, bozko m. Curr Pharm Des. 2013 Oct 14. Online ahead of print. Curr Pharm Des. 2013. PMID: 24180401 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters